María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
Hospital Virgen del Camino
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Hospital Virgen del Camino (10)
2021
2020
-
Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2020), 22, 6, (823-834), 10.1007/s12094-019-02211-x)
Clinical and Translational Oncology
-
Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Revista Espanola de Patologia, Vol. 53, Núm. 4, pp. 234-245
-
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 22, Núm. 6, pp. 823-834
-
Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain
Clinical and Translational Oncology, Vol. 22, Núm. 12, pp. 2253-2263
2018
-
Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH
Clinical and Translational Oncology, Vol. 20, Núm. 4, pp. 443-447
-
Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer
Revista Espanola de Patologia
2017
-
Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy
Clinical and Translational Oncology, Vol. 19, Núm. 2, pp. 219-226
-
Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists
Clinical and Translational Oncology, Vol. 19, Núm. 4, pp. 508-518
-
Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: A position statement of SEOM, SEAP and SEFH
Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 688-691